Cetero Completes 20,000th Trial
Cetero Research today announced that it has reached an industry milestone with the completion of its 20,000th early-phase clinical study.
This achievement highlights the range of study experience and therapeutic expertise that Cetero offers to pharmaceutical, biotechnology and generic clients.
In conducting 20,000 studies over the past 30 years, Cetero has developed considerable experience with normal healthy participants, special populations, and patients. Cetero currently delivers a 99 percent on-time recruitment rate.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
